Characterization of the Epidermal Growth Factor Receptor T790M Mutation in Colorectal Cancer

被引：2
作者：
Altunel, Erdem [1 ,2 ]
Aljamal, Abed Alhalim [1 ,2 ]
Mantyh, John [1 ]
Deak, Kristen [2 ]
Glover, Wayne [1 ,2 ]
Mccall, Shannon J. [2 ]
Datto, Michael [2 ]
Strickler, John [1 ]
Hsu, David S. [1 ,2 ]
机构：
[1] Duke Univ, Med Ctr, 3008 Snyderman Bldg,905 S LaSalle St, Durham, NC 27710 USA
[2] Duke Univ, Durham, NC 27710 USA
来源：
JCO PRECISION ONCOLOGY | 2018年 / 2卷
关键词：
D O I：
10.1200/PO.18.00194
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 7
页数：7
相关论文
共 11 条
  • [1] Third-Generation Tyrosine Kinase inhibitors Targeting epidermal Growth Factor Receptor Mutations in non-Small Cell Lung Cancer
    Barnes, Tristan A.
    O'Kane, Grainne M.
    Vincent, Mark David
    Leighl, Natasha B.
    [J]. FRONTIERS IN ONCOLOGY, 2017, 7
  • [2] AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
    Cross, Darren A. E.
    Ashton, Susan E.
    Ghiorghiu, Serban
    Eberlein, Cath
    Nebhan, Caroline A.
    Spitzler, Paula J.
    Orme, Jonathon P.
    Finlay, M. Raymond V.
    Ward, Richard A.
    Mellor, Martine J.
    Hughes, Gareth
    Rahi, Amar
    Jacobs, Vivien N.
    Brewer, Monica Red
    Ichihara, Eiki
    Sun, Jing
    Jin, Hailing
    Ballard, Peter
    Al-Kadhimi, Katherine
    Rowlinson, Rachel
    Klinowska, Teresa
    Richmond, Graham H. P.
    Cantarini, Mireille
    Kim, Dong-Wan
    Ranson, Malcolm R.
    Pao, William
    [J]. CANCER DISCOVERY, 2014, 4 (09) : 1046 - 1061
  • [3] Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib
    Ho, Chao-Chi
    Liao, Wei-Yu
    Lin, Chih-An
    Shih, Jin-Yuan
    Yu, Chong-Jen
    Yang, James Chih-Hsin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 567 - 572
  • [4] Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients
    Hu, Yuebi
    Alden, Ryan S.
    Odegaard, Justin I.
    Fairclough, Stephen R.
    Chen, Ruthia
    Heng, Jennifer
    Feeney, Nora
    Nagy, Rebecca J.
    Shah, Jayshree
    Ulrich, Bryan
    Gutierrez, Martin
    Lanman, Richard B.
    Garber, Judy E.
    Paweletz, Cloud P.
    Oxnard, Geoffrey R.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (23) : 7351 - 7359
  • [5] Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
    Kim, Mickey K.
    Osada, Takuya
    Barry, William T.
    Yang, Xiao Yi
    Freedman, Jennifer A.
    Tsamis, Katherine A.
    Datto, Michael
    Clary, Bryan M.
    Clay, Timothy
    Morse, Michael A.
    Febbo, Philip G.
    Lyerly, H. Kim
    Hsu, David S.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2012, 11 (07) : 1500 - 1509
  • [6] Mechanisms of resistance to EGFR-targeted drugs: lung cancer
    Morgillo, Floriana
    Della Corte, Carminia Maria
    Fasano, Morena
    Ciardiello, Fortunato
    [J]. ESMO OPEN, 2016, 1 (03)
  • [7] FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
    Odogwu, Lauretta
    Mathieu, Luckson
    Goldberg, Kirsten B.
    Blumenthal, Gideon M.
    Larkins, Erin
    Fiero, Mallorie H.
    Rodriguez, Lisa
    Bijwaard, Karen
    Lee, Eunice Y.
    Philip, Reena
    Fan, Ingrid
    Donoghue, Martha
    Keegan, Patricia
    McKee, Amy
    Pazdur, Richard
    [J]. ONCOLOGIST, 2018, 23 (03) : 353 - 359
  • [8] Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
    Pao, W
    Miller, VA
    Politi, KA
    Riely, GJ
    Somwar, R
    Zakowski, MF
    Kris, MG
    Varmus, H
    [J]. PLOS MEDICINE, 2005, 2 (03) : 225 - 235
  • [9] Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)
    Saad, Nibal
    Poudel, Aarati
    Basnet, Alina
    Gajra, Ajeet
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 1757 - 1765
  • [10] Histological and Molecular Evaluation of Patient-Derived Colorectal Cancer Explants
    Uronis, Joshua M.
    Osada, Takuya
    McCall, Shannon
    Yang, Xiao Yi
    Mantyh, Christopher
    Morse, Michael A.
    Lyerly, H. Kim
    Clary, Bryan M.
    Hsu, David S.
    [J]. PLOS ONE, 2012, 7 (06):
12